Skip to main content

Initial data from Israel unclear on preventing infections

Data from Israel's vaccination campaign only shows the vaccine against COVID-19 prevents serious illness so far.
GettyImages-1230911488.jpg

New data from Israel’s speedy vaccination campaign against COVID-19 offers information on the vaccine’s effectiveness.

The American-German Pfizer-BioNTech vaccine is effective in preventing serious illness resulting from the coronavirus, according to initial data. It is unclear whether the vaccine affects transmission of the virus, however, Agence France-Presse reported Wednesday, citing Israeli health experts.

Israel is currently leading the world in administering vaccines against COVID-19 on a per capita basis. The state has administered 58.83 vaccine doses per 100 people, according to Our World in Data. Vaccines against the coronavirus typically require two doses to be fully effective.

The report on the vaccine’s effectiveness shows that countries in the region may not immediately slow infection rates with the vaccine. Israel is currently experiencing a major coronavirus outbreak in spite of its vaccine rollout success.

It is possible further data will show the vaccine can indeed prevent infections. An Israeli health care source told Agence France-Presse that initial findings show a significant but not complete reduction in infections two weeks after the first dose is given. Israel also only tests people who have symptoms, meaning their infection rates do not include asymptomatic people who may be shedding the virus, according to the outlet.

Join hundreds of Middle East professionals with Al-Monitor PRO.

Business and policy professionals use PRO to monitor the regional economy and improve their reports, memos and presentations. Try it for free and cancel anytime.

Free

The Middle East's Best Newsletters

Join over 50,000 readers who access our journalists dedicated newsletters, covering the top political, security, business and tech issues across the region each week.
Delivered straight to your inbox.

Free

What's included:
Our Expertise

Free newsletters available:

  • The Takeaway & Week in Review
  • Middle East Minute (AM)
  • Daily Briefing (PM)
  • Business & Tech Briefing
  • Security Briefing
  • Gulf Briefing
  • Israel Briefing
  • Palestine Briefing
  • Turkey Briefing
  • Iraq Briefing
Expert

Premium Membership

Join the Middle East's most notable experts for premium memos, trend reports, live video Q&A, and intimate in-person events, each detailing exclusive insights on business and geopolitical trends shaping the region.

$25.00 / month
billed annually

Become Member Start with 1-week free trial

We also offer team plans. Please send an email to pro.support@al-monitor.com and we'll onboard your team.

What's included:
Our Expertise AI-driven

Memos - premium analytical writing: actionable insights on markets and geopolitics.

Live Video Q&A - Hear from our top journalists and regional experts.

Special Events - Intimate in-person events with business & political VIPs.

Trend Reports - Deep dive analysis on market updates.

All premium Industry Newsletters - Monitor the Middle East's most important industries. Prioritize your target industries for weekly review:

  • Capital Markets & Private Equity
  • Venture Capital & Startups
  • Green Energy
  • Supply Chain
  • Sustainable Development
  • Leading Edge Technology
  • Oil & Gas
  • Real Estate & Construction
  • Banking

Already a Member? Sign in

Start your PRO membership today.

Join the Middle East's top business and policy professionals to access exclusive PRO insights today.

Join Al-Monitor PRO Start with 1-week free trial